Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro(®)) and a varicella vaccine (VARIVAX(®)) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial

BACKGROUND: When this trial was initiated, the combined measles, mumps and rubella (MMR) vaccine was licensed for subcutaneous administration in all European countries and for intramuscular administration in some countries, whereas varicella vaccine was licensed only for subcutaneous administration....

Descripción completa

Detalles Bibliográficos
Autores principales: Gillet, Yves, Habermehl, Pirmin, Thomas, Stéphane, Eymin, Cécile, Fiquet, Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674599/
https://www.ncbi.nlm.nih.gov/pubmed/19366435
http://dx.doi.org/10.1186/1741-7015-7-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674599/
https://www.ncbi.nlm.nih.gov/pubmed/19366435
http://dx.doi.org/10.1186/1741-7015-7-16

Ejemplares similares